Columbia Technology Ventures

Submit a New Inquiry

Technology #cu15242 - Method to target valproic acid treatment for the negative symptoms of psychiatric disorders using pharmacogenomics

Columbia Technology Ventures contracts with Nouvant to provide this service.

Your inquiry will be sent to this technology's managers. All fields are required unless otherwise noted.



By submitting this inquiry you accept the terms of the Privacy Policy and Terms of Service.

Powered by Nouvant